Werewolf Therapeutics, Inc.
HOWL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $111 | $134 | $129 | $158 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $1 | $7 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $3 | $4 | $4 |
| Total Curr. Assets | $113 | $138 | $140 | $161 |
| Property Plant & Equip (Net) | $12 | $15 | $17 | $16 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $21 | $1 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $1 | $2 |
| Total NC Assets | $14 | $36 | $20 | $18 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $127 | $175 | $160 | $179 |
| Liabilities | – | – | – | – |
| Payables | $3 | $1 | $1 | $2 |
| Short-Term Debt | $2 | $8 | $2 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $1 | $7 | $0 |
| Other Curr. Liab. | $11 | $9 | $14 | $9 |
| Total Curr. Liab. | $15 | $19 | $24 | $12 |
| LT Debt | $36 | $44 | $13 | $15 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $0 | $1 | $0 |
| Total NC Liab. | $38 | $44 | $14 | $15 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $11 | $13 | $15 | $16 |
| Total Liabilities | $54 | $63 | $38 | $26 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$415 | -$344 | -$307 | -$253 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $488 | $455 | $429 | $406 |
| Total Equity | $73 | $111 | $122 | $153 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $127 | $175 | $160 | $179 |
| Net Debt | -$74 | -$82 | -$115 | -$142 |